Cargando…

Muscle Twitch Kinetics Are Dependent on Muscle Group, Disease State, and Age in Duchenne Muscular Dystrophy Mouse Models

Duchenne muscular dystrophy (DMD) is an X-linked disorder caused by the lack of functional dystrophin protein. In muscular dystrophy preclinical research, it is pertinent to analyze the force of the muscles affected by the disease to assess pathology and potential effectiveness of therapeutic interv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peczkowski, Kyra K., Rastogi, Neha, Lowe, Jeovanna, Floyd, Kyle T., Schultz, Eric J., Karaze, Tallib, Davis, Jonathan P., Rafael-Fortney, Jill A., Janssen, Paul M. L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545010/ https://www.ncbi.nlm.nih.gov/pubmed/33101056 http://dx.doi.org/10.3389/fphys.2020.568909

Ejemplares similares

Corrigendum: Muscle Twitch Kinetics Are Dependent on Muscle Group, Disease State, and Age in Duchenne Muscular Dystrophy Mouse Models
por: Peczkowski, Kyra K., et al.
Publicado: (2022)

The Angiotensin Converting Enzyme Inhibitor Lisinopril Improves Muscle Histopathology but not Contractile Function in a Mouse Model of Duchenne Muscular Dystrophy
por: Lowe, Jeovanna, et al.
Publicado: (2015)

Micro-dystrophin gene therapy prevents heart failure in an improved Duchenne muscular dystrophy cardiomyopathy mouse model
por: Howard, Zachary M., et al.
Publicado: (2021)

Mineralocorticoid receptor antagonism by finerenone is sufficient to improve function in preclinical muscular dystrophy
por: Lowe, Jeovanna, et al.
Publicado: (2020)

Metabolic Dysfunction and Altered Mitochondrial Dynamics in the Utrophin-Dystrophin Deficient Mouse Model of Duchenne Muscular Dystrophy
por: Pant, Meghna, et al.
Publicado: (2015)

Micro-dystrophin gene therapy demonstrates long-term cardiac efficacy in a severe Duchenne muscular dystrophy model
por: Piepho, Arden B., et al.
Publicado: (2023)

Mineralocorticoid receptor antagonists and glucocorticoids differentially affect skeletal muscle inflammation and pathology in muscular dystrophy
por: Howard, Zachary M., et al.
Publicado: (2022)

Genetic disruption of Ano5 in mice does not recapitulate human ANO5-deficient muscular dystrophy
por: Xu, Jing, et al.
Publicado: (2015)

Prednisolone Attenuates Improvement of Cardiac and Skeletal Contractile Function and Histopathology by Lisinopril and Spironolactone in the mdx Mouse Model of Duchenne Muscular Dystrophy
por: Janssen, Paul M. L., et al.
Publicado: (2014)

Functional muscle ischemia in Duchenne and Becker muscular dystrophy
por: Thomas, Gail D.
Publicado: (2013)

Medical management of muscle weakness in Duchenne muscular dystrophy
por: Rivera, Sarah R., et al.
Publicado: (2020)

Muscle-Specific SIRT1 Gain-of-Function Increases Slow-Twitch Fibers and Ameliorates Pathophysiology in a Mouse Model of Duchenne Muscular Dystrophy
por: Chalkiadaki, Angeliki, et al.
Publicado: (2014)

Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients
por: Capitanio, Daniele, et al.
Publicado: (2020)

Muscle architecture is associated with muscle fat replacement in Duchenne and Becker muscular dystrophies
por: Veeger, Thom T. J., et al.
Publicado: (2021)

Muscle Activation during Gait in Children with Duchenne Muscular Dystrophy
por: Ropars, Juliette, et al.
Publicado: (2016)

Longitudinal MRI quantification of muscle degeneration in Duchenne muscular dystrophy
por: Godi, Claudia, et al.
Publicado: (2016)

Epigenetic modifications in muscle regeneration and progression of Duchenne muscular dystrophy
por: Rugowska, Anna, et al.
Publicado: (2021)

Respiratory Muscle Strength and Cough Capacity in Patients with Duchenne Muscular Dystrophy
por: Kang, Seong-Woong, et al.
Publicado: (2006)

Circulating Muscle-specific miRNAs in Duchenne Muscular Dystrophy Patients
por: Li, Xihua, et al.
Publicado: (2014)

Skeletal Muscle Metabolism in Duchenne and Becker Muscular Dystrophy—Implications for Therapies
por: Heydemann, Ahlke
Publicado: (2018)

Epigenetic Regulators Modulate Muscle Damage in Duchenne Muscular Dystrophy Model
por: Bajanca, Fernanda, et al.
Publicado: (2017)

Quadriceps muscle strength in Duchenne muscular dystrophy and effect of corticosteroid treatment
por: Merlini, Luciano, et al.
Publicado: (2020)

Preserved thenar muscles in non‐ambulant Duchenne muscular dystrophy patients
por: Naarding, Karin J., et al.
Publicado: (2021)

MiRNAs and Muscle Regeneration: Therapeutic Targets in Duchenne Muscular Dystrophy
por: Aránega, Amelia Eva, et al.
Publicado: (2021)

Myosin Binding Protein-C Slow Phosphorylation is Altered in Duchenne Dystrophy and Arthrogryposis Myopathy in Fast-Twitch Skeletal Muscles
por: Ackermann, Maegen A., et al.
Publicado: (2015)

Systemic Inflammation in Duchenne Muscular Dystrophy: Association with Muscle Function and Nutritional Status
por: Cruz-Guzmán, Oriana del Rocío, et al.
Publicado: (2015)

Detection of the mutation may guide treatment of heart and muscle in Duchenne muscular dystrophy
por: Finsterer, Josef, et al.
Publicado: (2016)

A human in vitro model of Duchenne muscular dystrophy muscle formation and contractility
por: Nesmith, Alexander P., et al.
Publicado: (2016)

Targeting muscle stem cell intrinsic defects to treat Duchenne muscular dystrophy
por: Dumont, Nicolas A, et al.
Publicado: (2016)

Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future
por: Łoboda, Agnieszka, et al.
Publicado: (2020)

The Effect of Deflazacort Treatment on the Functioning of Skeletal Muscle Mitochondria in Duchenne Muscular Dystrophy
por: Dubinin, Mikhail V., et al.
Publicado: (2020)

Inflammation in Duchenne Muscular Dystrophy–Exploring the Role of Neutrophils in Muscle Damage and Regeneration
por: Tulangekar, Ankita, et al.
Publicado: (2021)

Differential Effects of Halofuginone Enantiomers on Muscle Fibrosis and Histopathology in Duchenne Muscular Dystrophy
por: Mordechay, Sharon, et al.
Publicado: (2021)

A Spotlight on T Lymphocytes in Duchenne Muscular Dystrophy—Not Just a Muscle Defect
por: Coles, Chantal A., et al.
Publicado: (2022)

Histological Methods to Assess Skeletal Muscle Degeneration and Regeneration in Duchenne Muscular Dystrophy
por: Dubuisson, Nicolas, et al.
Publicado: (2022)

Inflammasome Activity in the Skeletal Muscle and Heart of Rodent Models for Duchenne Muscular Dystrophy
por: Onódi, Zsófia, et al.
Publicado: (2023)

Absence of extraocular muscle pathology in Duchenne's muscular dystrophy: role for calcium homeostasis in extraocular muscle sparing
Publicado: (1995)

Muscle membrane integrity in Duchenne muscular dystrophy: recent advances in copolymer-based muscle membrane stabilizers
por: Houang, Evelyne M., et al.
Publicado: (2018)

Modulating fast skeletal muscle contraction protects skeletal muscle in animal models of Duchenne muscular dystrophy
por: Russell, Alan J., et al.
Publicado: (2023)

Survival in Duchenne muscular dystrophy
por: RALL, SUSANNE, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_pnifdqg634muagop7u15a15v2r